| scholarly article | Q13442814 |
| P50 | author | Sławomir Milewski | Q18398032 |
| Anthony J Hayes | Q57252389 | ||
| P2093 | author name string | Xiao-Qing Wei | |
| David W Williams | |||
| Edward Borowski | |||
| Sladjana Malic | |||
| Melanie J Wilson | |||
| Joanna Boros-Majewska | |||
| Natalia Salewska | |||
| P2860 | cites work | Pathogenesis and treatment of oral candidosis | Q24601191 |
| Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance | Q30701532 | ||
| Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy | Q33284054 | ||
| Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes | Q33745874 | ||
| Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. | Q33772099 | ||
| A novel injectable water-soluble amphotericin B-arabinogalactan conjugate | Q33977425 | ||
| Novel approaches in the rational design of antifungal agents of low toxicity | Q33986924 | ||
| Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity | Q61441063 | ||
| Significant Improvement of Antifungal Activity of Polyene Macrolides by Bisalkylation of the Mycosamine | Q64168912 | ||
| Quantitative structure-activity relationships in amphotericin B derivatives | Q68128015 | ||
| Voriconazole and multidrug resistance in Candida albicans | Q79787664 | ||
| Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis | Q80488600 | ||
| Oral candidosis in patients with advanced cancer | Q82778938 | ||
| Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice | Q83881382 | ||
| Biosynthetic engineering of polyene macrolides towards generation of improved antifungal and antiparasitic agents. | Q34011641 | ||
| Oral candidosis. | Q34116655 | ||
| Nystatin LF (Aronex/Abbott). | Q34375567 | ||
| Oral cancer prevention and control--the approach of the World Health Organization | Q34597352 | ||
| Oral candidal infections and antimycotics | Q34632651 | ||
| Amphotericin B and its new derivatives - mode of action | Q34998023 | ||
| Polyene macrolide antibiotics and their applications in human therapy | Q35060978 | ||
| Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia | Q35629661 | ||
| Diabetes mellitus as a contributory factor in oral candidosis | Q36471627 | ||
| Candida albicans pathogenicity mechanisms. | Q36845868 | ||
| Optimizing efficacy of Amphotericin B through nanomodification. | Q37178176 | ||
| Biofilm lifestyle of Candida: a mini review. | Q37348653 | ||
| Oral mucosal fungal infections. | Q37371876 | ||
| Interactions of Candida albicans with epithelial cells | Q37634125 | ||
| Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs | Q37699331 | ||
| Synthesis and biological evaluation of amphotericin B derivatives | Q37765817 | ||
| Candida biofilms and oral candidosis: treatment and prevention | Q37816546 | ||
| Candida albicans, a major human fungal pathogen | Q37871475 | ||
| Host-pathogen interactions and virulence-associated genes during Candida albicans oral infections | Q37873640 | ||
| Life, death, and in-between: meanings and methods in microbiology. | Q37894495 | ||
| Current concepts in antifungal pharmacology | Q37908856 | ||
| Candida albicans dimorphism as a therapeutic target | Q37965698 | ||
| Tissue-engineered oral mucosa. | Q37977812 | ||
| Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity | Q38071670 | ||
| Mechanism of activity and toxicity of Nystatin-Intralipid | Q39255260 | ||
| Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. | Q39558196 | ||
| Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes | Q39782465 | ||
| In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination | Q40103619 | ||
| Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC. | Q40289243 | ||
| In vitro method to study antifungal perfusion in Candida biofilms | Q41042117 | ||
| Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds | Q43195949 | ||
| Antifungal resistance of candidal biofilms formed on denture acrylic in vitro | Q43622404 | ||
| MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cells | Q43713701 | ||
| Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals | Q44206099 | ||
| Studies of the effects of antifungal cationic derivatives of amphotericin B on human erythrocytes | Q45215521 | ||
| Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei | Q46236026 | ||
| The reproductive and developmental toxicity of the antifungal drug Nyotran (liposomal nystatin) in rats and rabbits | Q46355403 | ||
| In vitro susceptibility of oral Candida to seven antifungal agents | Q46765203 | ||
| Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B. | Q46807515 | ||
| P433 | issue | 5 | |
| P921 | main subject | nystatin | Q251005 |
| P304 | page(s) | 341-355 | |
| P577 | publication date | 2014-06-13 | |
| P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
| P1476 | title | Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis | |
| P478 | volume | 203 |
| Q36411038 | Alginate oligosaccharides modify hyphal infiltration of Candida albicans in an in vitro model of invasive human candidosis. |
| Q48166226 | Antifungal Activity of Commercial Essential Oils and Biocides against Candida Albicans |
| Q35961258 | Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their mode of action against Candida albicans |
| Q37134402 | Effect of Antimicrobial Denture Base Resin on Multi-Species Biofilm Formation |
| Q50659658 | Redesign of antifungal polyene glycosylation: engineered biosynthesis of disaccharide-modified NPP. |
Search more.